Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q2 2021 · 10-Q
Revenue$125.00K$125.00K±0.0% vs Q2 2020 Net Income-$5.45M-$5.45MN/M vs Q2 2020 EPS Diluted-$0.06-$0.06N/M vs Q2 2020 Operating Income-$5,071,402N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,712,938N/M Margins · derivedOperating margin-4057.1%−243.5 pt vs Q2 2020
Net margin-4358.7%−84.4 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 12, 2021 · 43 d after period end